13G Filing: Great Point Partners and Catalyst Pharmaceuticals Inc. (CPRX)

Page 5 of 10

Page 5 of 10 – SEC Filing

CUSIP
No.   14888U101
13G Page
5 of 9 Pages
Item 1.
(a) Name of Issuer
Catalyst Pharmaceuticals, Inc.
(b) Address of Issuer’s Principal Executive Offices
355 Alhambra Circle, Suite 1250, Coral Gables, FL 33134
Item 2.
(a) Name of Person Filing
Great Point Partners, LLC
Dr. Jeffrey R. Jay, M.D.
Mr. David Kroin
The Reporting Persons have entered into a Joint Filing Agreement,
dated December 8, 2017, a copy of which is filed with this Schedule 13G as Exhibit A, pursuant to which the Reporting Persons have
agreed to file this statement jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act.
(b) Address of Principal Business Office, or if none, Residence
The address of the principal business office of each of the Reporting Persons is
165 Mason Street, 3rd Floor
Greenwich, CT 06830
(c) Citizenship
Great Point Partners, LLC is a limited liability company organized
under the laws of the State of Delaware. Dr. Jeffrey R. Jay, M.D. is a citizen of the United States. Mr. David Kroin is a citizen
of the United States.
(d) Title of Class of Securities
Common Stock
(e) CUSIP Number
14888U101
Item 3. If this statement is filed pursuant to §240.13d-1(b) or 240.13d.2(b) or (c), check whether the person filing is a:
Not Applicable.
(a) o Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o)
(b) o Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) o Insurance company as defined in Section 3(a)(19) of the Act (15. U.S.C. 78c).
(d) o Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e) x An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

Follow Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX)

Page 5 of 10